JAOA Vol 106 No 10 October 2006 589-
Response
John M. McPartland, DO, Clinical Assistant Professor
Department of Family Practice College of Medicine University of Vermont
Middlebury
I thank Dr Stefano for elaborating on the mechanisms proposed in our June
2005 original
contribution.1 There
is "NO" doubt that future research collaborations will open new
doors for the osteopathic physicians' use of osteopathic manipulative
treatment. Basic scientists with excellent pedigrees are conducting
endocannabinoid research at osteopathic medical
schools.2,3
Osteopathic medicine needs outcomes-based research, but we also need to
explore the mechanisms by which our treatments work.
References
1. McPartland JM, Giuffrida A, King J, Skinner E, Scotter J, Musty RE.
Cannabimimetic effects of osteopathic manipulative treatment. J Am
Osteopath Assoc. 2005;105:283291. Available at:
http://www.jaoa.org/cgi/content/full/105/6/283.
Accessed September 27, 2006.2. Darmani NA. Methods evaluating cannabinoid and endocannabinoid
effects on gastrointestinal functions. Methods Mol
Med. 2006;123:169
189.[Medline]
3. Ogawa A, Meng ID. The cannabinoid receptor agonist, WIN 55,212-2,
inhibits cool-specific lamina I medullary dorsal horn neurons.
Neuroscience. Epub August29
, 2006. In press.